Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares soared 57.05 percent to close at $9.80 a share Thursday. The stock traded between $6.29 and $14.17 on volume 3.64 million shares traded. The company, whose focuses developing treatments for liver disease, was boosted by the success of Intercept Pharmaceuticals’ treatment for steatohepatitis. Shares of Conatus Pharmaceuticals have gained approximately 3.0 percent in the past year.
Get more information on Conatus Pharmaceuticals and free access to the in-depth equity report at:
Galectin Therapeutics Inc. (NASDAQ: GALT) shares jumped 59.15 percent to close at $13.48 a share Thursday. The stock traded between $8.75 and $14.20 on volume 7.08 million shares traded. The company, which also creates new therapies for fibrotic disease, was boosted by the success of Intercept Pharmaceuticals’ treatment for steatohepatitis. Shares of Galectin Therapeutics have fallen approximately 550.0 percent in the past year.
Get more information on Galectin Therapeutics and free access to the in-depth equity report at:
Dot Hill Systems Corp. (NASDAQ: HILL) shares gained 15.27 percent to close at $4.00 a share Thursday. The stock traded between $3.44 and $4.35 on volume 3.09 million shares traded. The company raised its guidance for full-year 2013 non-GAAP revenue to a range of $208.0 million to $208.5 million, from its previous guidance of $202.0 million to $207.0 million. Shares of Dot Hill Systems have gained approximately 260.0 percent in the past year.
Get more information on Dot Hill Systems free access to the in-depth equity report at:
MagneGas Corporation (NASDAQ: MNGA) shares surged 49.50 percent to close at $1.51 a share Thursday. The stock traded between $1.31 and $2.36 on volume of 8.13 million shares traded. The company announced that it has signed a development contract with the Italian National Alternative Energy Laboratory. Shares of MagneGas have fallen approximately 1.0 percent in the past year.
Get more information on MagneGas and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities